| 6400.165(g) | Individual #1 is prescribed medications to treat symptoms of the psychiatric illness, obsessive compulsive disorder. The reviews of medications conducted 11/9/20, 9/10/20, 6/11/20 and 10/30/19 did not include the need to continue the medications. | If a medication is prescribed to treat symptoms of a psychiatric illness, there shall be a review by a licensed physician at least every 3 months that includes to document the reason for prescribing the medication, the need to continue the medication and the necessary dosage. | On 11/24/2020, the program managers and program coordinators have been retrained on the 6400.165.g regulation if a medication is prescribed to treat symptoms of a psychiatric illness, there shall be a review by a licensed physician at least every 3 months that includes documentation of the reason for prescribing the medication, the need to continue the medication and the necessary dosage. A new psychiatric medication review form was created and effective immediately, will be used in addition to the appointment consultation form. All forms will be uploaded to the ECR. The program manager and program coordinator will review the appointment documentation to ensure that the scheduled appointment is within the 3-month time frame, includes the reason for prescribing the medication, the need to continue the medication and the necessary dosage. An additional review will be completed by utilizing a monthly clinician report in the ECR and ongoing audits will be conducted by the quality team.
Supporting documentation of the retraining of the program managers and program coordinators, the new psychiatric medication review form and the example of the ECR monthly clinician report will be submitted. |
11/25/2020
| Implemented |